S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
NASDAQ:ANGO

AngioDynamics (ANGO) Stock Price, News & Analysis

$6.26
+0.14 (+2.29%)
(As of 04/19/2024 ET)
Today's Range
$6.06
$6.27
50-Day Range
$5.27
$7.03
52-Week Range
$5.26
$11.38
Volume
479,291 shs
Average Volume
583,010 shs
Market Capitalization
$250.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.25

AngioDynamics MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
127.6% Upside
$14.25 Price Target
Short Interest
Healthy
5.62% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.99
Upright™ Environmental Score
News Sentiment
0.90mentions of AngioDynamics in the last 14 days
Based on 3 Articles This Week
Insider Trading
Acquiring Shares
$67,000 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.57) to ($0.55) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.50 out of 5 stars

Medical Sector

88th out of 912 stocks

Surgical & Medical Instruments Industry

14th out of 98 stocks

ANGO stock logo

About AngioDynamics Stock (NASDAQ:ANGO)

AngioDynamics, Inc. provides invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology in the United States and internationally. It offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium for treatment of peripheral arterial disease. The company's thrombus management portfolio includes AlphaVac system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac circuit is indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. In addition, it offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. The company also provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

ANGO Stock Price History

ANGO Stock News Headlines

Secret Bull Market Starts in This Unusual Sector
"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.
Secret Bull Market Starts in This Unusual Sector
"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.
AngioDynamics: Fiscal Q3 Earnings Snapshot
AngioDynamics Q3 Loss Sharply Widens; Slashes FY24 Outlook
AngioDynamics Settles All Patent Litigation With C.R. Bard
See More Headlines
Receive ANGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AngioDynamics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
7/12/2023
Today
4/19/2024
Fiscal Year End
5/31/2024
Next Earnings (Estimated)
7/10/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:ANGO
CUSIP
03475V10
Employees
815
Year Founded
1988

Price Target and Rating

Average Stock Price Target
$14.25
High Stock Price Target
$18.00
Low Stock Price Target
$10.00
Potential Upside/Downside
+127.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$-52,440,000.00
Pretax Margin
-61.53%

Debt

Sales & Book Value

Annual Sales
$338.75 million
Cash Flow
$1.08 per share
Book Value
$5.46 per share

Miscellaneous

Free Float
38,012,000
Market Cap
$250.78 million
Optionable
Optionable
Beta
0.66

Social Links

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives


ANGO Stock Analysis - Frequently Asked Questions

Should I buy or sell AngioDynamics stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AngioDynamics in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ANGO shares.
View ANGO analyst ratings
or view top-rated stocks.

What is AngioDynamics' stock price target for 2024?

4 brokers have issued 1-year price objectives for AngioDynamics' shares. Their ANGO share price targets range from $10.00 to $18.00. On average, they anticipate the company's share price to reach $14.25 in the next twelve months. This suggests a possible upside of 127.6% from the stock's current price.
View analysts price targets for ANGO
or view top-rated stocks among Wall Street analysts.

How have ANGO shares performed in 2024?

AngioDynamics' stock was trading at $7.84 at the beginning of 2024. Since then, ANGO stock has decreased by 20.2% and is now trading at $6.26.
View the best growth stocks for 2024 here
.

Are investors shorting AngioDynamics?

AngioDynamics saw a decline in short interest in March. As of March 31st, there was short interest totaling 2,250,000 shares, a decline of 8.5% from the March 15th total of 2,460,000 shares. Based on an average trading volume of 575,400 shares, the short-interest ratio is currently 3.9 days.
View AngioDynamics' Short Interest
.

When is AngioDynamics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 10th 2024.
View our ANGO earnings forecast
.

How were AngioDynamics' earnings last quarter?

AngioDynamics, Inc. (NASDAQ:ANGO) issued its quarterly earnings data on Wednesday, July, 12th. The medical instruments supplier reported $0.02 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.02. The medical instruments supplier had revenue of $91.10 million for the quarter, compared to analyst estimates of $90.73 million. AngioDynamics had a negative net margin of 60.21% and a negative trailing twelve-month return on equity of 3.48%. AngioDynamics's revenue was up 4.7% on a year-over-year basis. During the same period in the prior year, the firm posted $0.01 EPS.

What ETF holds AngioDynamics' stock?

Invesco Nasdaq Future Gen 200 ETF holds 7,477 shares of ANGO stock, representing 0.65% of its portfolio.

What guidance has AngioDynamics issued on next quarter's earnings?

AngioDynamics issued an update on its FY 2024 earnings guidance on Thursday, April, 4th. The company provided earnings per share (EPS) guidance of -0.580--0.540 for the period, compared to the consensus estimate of -0.430. The company issued revenue guidance of $270.0 million-$275.0 million, compared to the consensus revenue estimate of $312.1 million.

What is James C. Clemmer's approval rating as AngioDynamics' CEO?

34 employees have rated AngioDynamics Chief Executive Officer James C. Clemmer on Glassdoor.com. James C. Clemmer has an approval rating of 50% among the company's employees. This puts James C. Clemmer in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. 47.0% of employees surveyed would recommend working at AngioDynamics to a friend.

What other stocks do shareholders of AngioDynamics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AngioDynamics investors own include General Electric (GE), Intel (INTC), Oasis Petroleum (OAS), Advanced Micro Devices (AMD), Freeport-McMoRan (FCX), Amicus Therapeutics (FOLD), Rigel Pharmaceuticals (RIGL), Accuray (ARAY), Celldex Therapeutics (CLDX) and Chimerix (CMRX).

Who are AngioDynamics' major shareholders?

AngioDynamics' stock is owned by many different retail and institutional investors. Top institutional investors include Allspring Global Investments Holdings LLC (0.02%). Insiders that own company stock include Chad Thomas Campbell, Dave Helsel, James C Clemmer, James C Clemmer, Scott Centea, Stephen A Trowbridge and Wesley Johnson.
View institutional ownership trends
.

How do I buy shares of AngioDynamics?

Shares of ANGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does AngioDynamics have any subsidiaries?
The following companies are subsidiares of AngioDynamics: AngioDynamics Canada Inc., AngioDynamics France SARL, AngioDynamics Medical Brasil Participacoes Ltda., AngioDynamics Netherlands B. V., AngioDynamics UK Limited, AngioDynamics VA LLC, Clinical Devices, Eximo Medical Ltd., FlowMedica, NM Holding Company Inc., Navilyst Medical Holdings Inc., Navilyst Medical Inc., Oncovionic, RITA Medical Systems, RITA Medical Systems LLC, RadiaDyne LLC, and Vortex Medical.
Read More
This page (NASDAQ:ANGO) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners